Tech Company Financing Transactions

Synthekine Funding Round

Canaan Partners, Samsara BioCapital and The Column Group participated in a $82 million Series A venture round for Synthekine. The round closed on 9/18/2020.

Transaction Overview

Company Name
Synthekine
Announced On
9/18/2020
Transaction Type
Venture Equity
Amount
$82,000,000
Round
Series A
Investors

Canaan Partners (Lead Investor) (Julie Grant)

Samsara BioCapital (Lead Investor) (Srinivas Akkaraju)

The Column Group (Lead Investor) (Timothy Kutzkey)

Proceeds Purpose
Proceeds from this Series A financing will be used to advance Synthekine's lead therapeutic programs into clinical studies, expand its discovery pipeline and hone its proprietary cytokine engineering platforms.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1505 O'Brien Dr.
Menlo Park, CA 94025
USA
Phone
(650) 271-9888
Website
www.synthekine.com
Email Address
Not Recorded
Overview
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific, selective and potent cytokine therapies. Our targeted protein engineering guided by our deep experience in immunology provides transformative immunotherapies for the treatment of cancer and autoimmune disorders.
Profile
Synthekine LinkedIn Company Profile
Social Media
Synthekine Company Twitter Account
Company News
Synthekine News
Facebook
Synthekine on Facebook
YouTube
Synthekine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Debanjan Ray
  Debanjan Ray LinkedIn Profile  Debanjan Ray Twitter Account  Debanjan Ray News  Debanjan Ray on Facebook
Chief Medical Officer
Naiyer Rizvi
  Naiyer Rizvi LinkedIn Profile  Naiyer Rizvi Twitter Account  Naiyer Rizvi News  Naiyer Rizvi on Facebook
Vice President
Richard Murphy
  Richard Murphy LinkedIn Profile  Richard Murphy Twitter Account  Richard Murphy News  Richard Murphy on Facebook
Vice President
Gregory Yedinak
  Gregory Yedinak LinkedIn Profile  Gregory Yedinak Twitter Account  Gregory Yedinak News  Gregory Yedinak on Facebook
VP - Bus. Development
Martin Oft
  Martin Oft LinkedIn Profile  Martin Oft Twitter Account  Martin Oft News  Martin Oft on Facebook
VP - Finance
Robin Knifsend
  Robin Knifsend LinkedIn Profile  Robin Knifsend Twitter Account  Robin Knifsend News  Robin Knifsend on Facebook
VP - Operations
Christine Rocha
  Christine Rocha LinkedIn Profile  Christine Rocha Twitter Account  Christine Rocha News  Christine Rocha on Facebook
VP - R & D
Robert Kastelein
  Robert Kastelein LinkedIn Profile  Robert Kastelein Twitter Account  Robert Kastelein News  Robert Kastelein on Facebook
VP - R & D
Patrick Lupardus
  Patrick Lupardus LinkedIn Profile  Patrick Lupardus Twitter Account  Patrick Lupardus News  Patrick Lupardus on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/18/2020: JupiterOne venture capital transaction
Next: 9/18/2020: Zuper venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.